OpenAPS – Still changing the diabetes world…
If you don’t remember, back in May 2017 (some two and a half years ago), Dana wrote a post on her blog with the title […]
Artificial Pancreas
Control:IQ vs 670G – Which is better? The pivotal trial results are in.
With news that the Tandem T:Slim X2 Control:IQ pivotal study results have been published, I thought it would be worth comparing the data to that […]
Masquerades and Feints – using DIY diabetes terms nefariously
That’s a very blunt headline making a pretty clear statement about my point of view on this topic, but what is the topic? If you […]
Tandem’s T:Slim X2 and Control-IQ. What do we know?
With the recent news that Tandem have suspended their Control-IQ trial due to issues with it’s behaviour under certain CGM circumstances that may cause a […]
Understanding SMB and oref1
Continuing in this occasional series of explanations of the functions within OpenAPS/AndroidAPS/Trio, this one looks at SMB, and what is usually referred to as oref1. […]
Diabeloop. The Second Hybrid Closed Loop system to get a CE mark….
It never rains, but it pours, as they like to say in the western parts of the British Isles. And that seems true for Artificial […]
Rise of the Machines – Technology and “patient-driven” innovation in the treatment of diabetes #T1DRoM
On Saturday, if you didn’t know already, we ran a first for the UK. A day’s conference focusing on Diabetes Technology, and majoring on “Patient […]
A day without a loop – trying to quantify the difference between Sugar Surfing and looping #WeAreNotWaiting
I’ve often mentioned that one of the biggest benefits of using a loop (of any sort) is that you get time back. I’ve also estimated […]
Defining an “Artificial Pancreas”. Where are we with DIY systems? #WeAreNotWaiting
Back in 2013, in the US, Medtronic launched the 530G pump, and everyone and his dog called it an artificial pancreas. As Scott Hanselmann stated […]
Data and user interventions. Multiple challenges for future artificial pancreas systems.
If there’s one thing I’ve learned from my experiences with Fiasp over the past month or so, it’s how important access to my data […]